Improvement in health‐related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX 326 Pivotal Study
Year: 2013
Type: article
Source: Haemophilia
DOI: 10.1111/hae.12315
Authors: J. Windyga, V. W. Lin, J. D. Epstein, D. Ito, Y. Xiong, B. E. Abbuehl, J. H. Ramirez
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Baxter Healthcare Corporation
OpenAlex ID: W2003459897
